TRIPS Waiver proposal in Geneva mobilizes lobbyists in capitals around the world
Feeling the heat, Big Pharma has been using its financial clout to push back and engage in a frantic lobbying effort to influence governments not to join the project, documents from the US Senate and other organizations show.